Overview
Peter Orio-Iii is a Radiation Oncologist practicing medicine in Boston, Massachusetts.
Dr. Orio-Iii is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.
Dr. Orio-Iii is board certified in Radiation Oncology. He is actively involved in clinical research, co-authoring 1 peer reviewed article. Dr. Orio-Iii is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Boston, MA 02115
75 Francis Street, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital
Brian Alexander is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Alexander is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Dana-Farber Brigham Cancer Center
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Mak is board certified in Radiation Oncology. Dr. Mak is currently accepting new patients.
Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology
David Kozono is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Kozono is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Kozono is board certified in Radiation Oncology. Dr. Kozono is currently accepting new patients.
Frequently Asked Questions about Dr. Peter F. Orio-Iii
How do I make an appointment with Dr. Peter F. Orio-Iii?
You can book an appointment with Dr. Peter F. Orio-Iii by calling their office at 617-632-7325. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Peter F. Orio-Iii a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter F. Orio-Iii is classified as an Distinguished expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Peter F. Orio-Iii specialize in?
While Dr. Peter F. Orio-Iii is a Radiation Oncology, they have specific expertise in Familial Prostate Cancer, Prostate Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Peter F. Orio-Iii participate in research or clinical trials?
Yes. Dr. Peter F. Orio-Iii has published 1 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Dr. Peter F. Orio-Iii's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Peter F. Orio-Iii accept my insurance?
Dr. Peter F. Orio-Iii accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-7325 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Orio-Iii isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Orio-Iii isDistinguished. Learn about Prostate Cancer.
- Experienced
- Muscle Invasive Bladder CancerDr. Orio-Iii isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Orio-Iii isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.